TR201911128T4 - Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı. - Google Patents

Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı. Download PDF

Info

Publication number
TR201911128T4
TR201911128T4 TR2019/11128T TR201911128T TR201911128T4 TR 201911128 T4 TR201911128 T4 TR 201911128T4 TR 2019/11128 T TR2019/11128 T TR 2019/11128T TR 201911128 T TR201911128 T TR 201911128T TR 201911128 T4 TR201911128 T4 TR 201911128T4
Authority
TR
Turkey
Prior art keywords
fhbp
nessseria
menuinulludis
vaccination
relates
Prior art date
Application number
TR2019/11128T
Other languages
English (en)
Inventor
Tang Christoph
Lea Susan
Original Assignee
Univ Oxford Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oxford Innovation Ltd filed Critical Univ Oxford Innovation Ltd
Publication of TR201911128T4 publication Critical patent/TR201911128T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Buluş, bir yabani tür V2 fHbp üzerinden artmış stabiliteye sahip bir modifiye edilmiş V2 fHbp; SEKANS KİMLİK NUMARASI: 1'in sekansına en az %85 özdeşliğe sahip bir amino asit sekansına sahip bir modifiye edilmiş V2 fHbp ile ilgilidir, burada hem Ser137 hem de Gly138 mutasyona uğramaktadır veya hem Val112 hem de Leu114 mutasyona uğramaktadır; ayrıca buluş immünojenik, farmasötik ve aşı bileşimleri; nükleik asit ve bir konak hücre ve bu tür bileşimlerin kullanım yöntemleri ile ilgilidir.
TR2019/11128T 2012-08-23 2013-08-22 Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı. TR201911128T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1215005.8A GB201215005D0 (en) 2012-08-23 2012-08-23 Stabilised meningitis vaccine

Publications (1)

Publication Number Publication Date
TR201911128T4 true TR201911128T4 (tr) 2019-08-21

Family

ID=47045261

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/11128T TR201911128T4 (tr) 2012-08-23 2013-08-22 Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı.

Country Status (14)

Country Link
US (1) US9629905B2 (tr)
EP (1) EP2887956B1 (tr)
AU (1) AU2013304832B2 (tr)
CY (1) CY1126292T1 (tr)
DK (1) DK2887956T3 (tr)
ES (1) ES2739616T3 (tr)
GB (1) GB201215005D0 (tr)
HU (1) HUE044495T2 (tr)
LT (1) LT2887956T (tr)
PL (1) PL2887956T3 (tr)
PT (1) PT2887956T (tr)
SI (1) SI2887956T1 (tr)
TR (1) TR201911128T4 (tr)
WO (1) WO2014030003A1 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS61246B1 (sr) 2014-02-28 2021-01-29 Glaxosmithkline Biologicals Sa Modifikovani meningokokni fhbp polipeptidi
EA038940B1 (ru) 2014-07-17 2021-11-12 Глаксосмитклайн Байолоджикалс С.А. Менингококковые вакцины
CN106795208A (zh) * 2014-07-17 2017-05-31 葛兰素史密丝克莱恩生物有限公司 修饰的脑膜炎球菌fHbp多肽
RU2714248C2 (ru) 2014-07-23 2020-02-13 Чилдрен'З Хоспитал Энд Рисёрч Сентер Эт Окленд Варианты фактор н-связывающего белка и способы их применения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034345B2 (en) * 2005-01-27 2015-05-19 Children's Hospital & Research Center Oakland GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
EP2631245A1 (en) 2008-03-10 2013-08-28 Children's Hospital & Research Center at Oakland Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use

Also Published As

Publication number Publication date
AU2013304832A1 (en) 2015-03-05
GB201215005D0 (en) 2012-10-10
US9629905B2 (en) 2017-04-25
ES2739616T3 (es) 2020-02-03
PL2887956T3 (pl) 2019-10-31
SI2887956T1 (sl) 2019-09-30
HUE044495T2 (hu) 2019-10-28
CY1126292T1 (el) 2024-02-16
WO2014030003A1 (en) 2014-02-27
EP2887956A1 (en) 2015-07-01
EP2887956B1 (en) 2019-07-03
PT2887956T (pt) 2019-08-07
LT2887956T (lt) 2019-08-12
AU2013304832B2 (en) 2017-07-20
US20150190494A1 (en) 2015-07-09
DK2887956T3 (da) 2019-08-05

Similar Documents

Publication Publication Date Title
CY1126292T1 (el) Παραλλαγμα της fhbp του neisseria meningitidis και χρηση του για εμβολιασμο
CY1120319T1 (el) Πρωτεϊνες συντηξης και εμβολια συνδυασμου που περιλαμβανουν haemophilus influenzae πρωτεϊνη ε και πιλινη α
NZ702145A (en) Bluetongue virus recombinant vaccines and uses thereof
EP3563865A3 (en) Prostate-associated antigens and vaccine-based immunotherapy regimens
BR112014019901A8 (pt) Proteínas de fator viii recombinante
NZ733168A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
BR112018017307A2 (pt) molécula de ácido nucleico isolada, composição, e, métodos para indução de uma resposta imune contra um zika vírus, para tratamento de um indivíduo e para prevenção de uma infecção por zika vírus
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
EA201692359A1 (ru) Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
EA201891460A1 (ru) Композиция дендритных клеток
MX2018010483A (es) Inmunogenos para vacunacion contra vih.
EA201290876A1 (ru) Композиции индуцированных дендритных клеток и их использование
BR112014011560A2 (pt) complexos imunogênicos de carbômeros polianiônicos e polipeptídeos env, e métodos de fabricação e uso dos mesmos
EA201500054A1 (ru) Аттенуированные вакцины против streptococcus suis и способы их получения и применения
EA201590794A1 (ru) Рекомбинантные нейротоксины clostridium botulinum
EA201491643A1 (ru) Идентификация мутаций канал-опсина-2 (chop2) и способы применения
BR112013030396A2 (pt) polipeptídeo, polinucleotídeo, vetor, célula hospedeira, composição imunogênica, vacina, e, uso de uma composição imunogênica ou de uma vacina
BR112015000585A2 (pt) cepas mutantes de mycoplasma hyopneumoniae
PH12015502353B1 (en) Fusion polypeptides and vaccines
CY1124110T1 (el) Συνθεσεις και μεθοδοι μεταλλαγμενου παραγοντα viii
WO2013177593A3 (en) Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies
AR128395A2 (es) Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9
IN2014DN09963A (tr)
PH12017501100A1 (en) Recombinant swinepox virus and vaccines
EA201390811A1 (ru) Пептиды tomm34 и содержащие их вакцины